세계의 정밀 진단 시장 보고서(2025년)
Precision Diagnostics Global Market Report 2025
상품코드 : 1824445
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

정밀 진단 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 14.6%로 1,912억 5,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 액체 생검 응용의 확대, 인공지능(AI)의 통합, 동반진단 수요 증가, 포인트 오브 케어 검사의 확대, 집단 건강 관리의 대처에 기인하는 것으로 예측됩니다. 예측기간의 주요 동향으로는 시퀀싱의 기술 혁신, 멀티오믹스 기술의 진보, 디지털 퍼솔로지의 대두, 리얼 월드 에비던스의 통합, 연구개발에 있어서의 공동연구 등이 있습니다.

향후 5년간의 성장률 14.6%라고 하는 예측은 전회의 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰로 인해 한국과 독일에서 개발된 유전체 분석 도구의 가격이 상승하고, 맞춤 치료 계획의 지연과 종양 치료비의 상승을 초래함으로써 미국에서 차세대 시퀀서(NGS) 패널의 도입을 방해할 수 있습니다. 또한 상호관세나 무역마찰 및 제한의 격화에 의한 세계경제 및 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.

정밀 진단 시장은 만성 질환의 유병률이 증가함에 따라 성장할 것으로 예측됩니다. 만성 질환은 3개월 이상 지속되어 시간이 지남에 따라 악화될 수 있기 때문에 정밀 진단 솔루션에 대한 수요가 증가하고 있습니다. 정밀 진단은 만성 질환 환자의 건강 관리 모델을 관리하는 데 중요한 역할을 하며 정확한 질병 진단을 제공합니다. 예를 들어, 2023년 1월에 국립의학 도서관이 발표한 데이터에 따르면, 미국에서 적어도 하나의 만성 질환을 가진 50세 이상의 환자 수는 2050년까지 1억 4,266만 명에 달할 것으로 예측되며, 만성 질환 증가 추세에 대응하는 정밀 진단의 역할이 강조되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Precision diagnostics is a subset of precision medicine, focusing on utilizing individual data, including genetic, environmental, and lifestyle information, to enhance the prevention, diagnosis, and treatment of illnesses in healthcare. It involves providing detailed genetic information about a patient's clinical history to aid in the treatment process.

The primary types of precision diagnostics include genetic tests, esoteric tests, and others. Genetic tests involve laboratory examinations aimed at identifying differences in an individual's DNA, such as alterations in chromosomes, genes, or gene expression within their cells or tissues. Various technologies are employed, including next-generation sequencing (NGS), polymerase chain reaction (PCR), in situ hybridization (ISH), mass spectrometry, immunohistochemistry (IHC), and others. These technologies find applications in various fields such as oncology, infectious diseases, cardiovascular health, neurology, genetic disorders, and others. Precision diagnostics are utilized by hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The precision diagnostics market research report is one of a series of new reports from The Business Research Company that provides precision diagnostics market statistics, including precision diagnostics industry global market size, regional shares, competitors with a precision diagnostics market share, detailed precision diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the precision diagnostics industry. This precision diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision diagnostics market size has grown rapidly in recent years. It will grow from $98.14 billion in 2024 to $110.94 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to genomic research advances, the rise of personalized medicine, increasing prevalence of chronic diseases, patient empowerment and informed decision-making, healthcare system transition towards value-based care, government initiatives and funding.

The precision diagnostics market size is expected to see rapid growth in the next few years. It will grow to $191.25 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to expansion of liquid biopsy applications, integration of artificial intelligence (AI), growing demand for companion diagnostics, expansion of point-of-care testing, population health management initiatives. Major trends in the forecast period include technological innovations in sequencing, advancements in multi-omics technologies, rise of digital pathology, real-world evidence integration, collaborations in research and development.

The forecast of 14.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of next-generation sequencing (NGS) panels by inflating prices of genomic analysis tools developed in South Korea and Germany, resulting in delayed personalized treatment plans and higher oncology care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The precision diagnostics market is poised for growth, driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting three months or more and potentially worsening over time, prompt a growing demand for precise diagnostic solutions. Precision diagnostics play a crucial role in managing healthcare models for patients with chronic conditions, offering accurate disease diagnosis. For instance, data from the National Library of Medicine in January 2023 indicates that the number of individuals aged 50 and older in the US with at least one chronic condition is projected to reach 142.66 million by 2050, emphasizing the role of precision diagnostics in addressing the rising prevalence of chronic diseases.

An additional factor contributing to the growth of the precision diagnostics market is the increased spending on healthcare. Greater healthcare spending allocates substantial resources to advanced diagnostic solutions, fostering the development and widespread adoption of precision diagnostics. This aligns with the industry's commitment to delivering personalized and effective healthcare solutions. According to the 2021-2030 National Health Expenditure (NHE) report from the Centers for Medicare & Medicaid Services in March 2022, national health spending is expected to grow by 5.1% annually between 2021 and 2030, reaching nearly $6.8 trillion. The projected growth in healthcare spending, with annual increases in Medicare and Medicaid spending, is a key driver of the precision diagnostics market.

Leading companies in the precision diagnostics market are concentrating on innovative therapies, including the introduction of AI-driven video analysis tools that enhance patient engagement and facilitate the understanding of complex medical data, empowering individuals to take control of their health. An AI-driven video analysis tool utilizes artificial intelligence to analyze video content, simplifying intricate information such as health reports by highlighting essential parameters and providing clear insights for better comprehension and informed decision-making. For example, in August 2024, Healthians, an India-based diagnostic firm, launched an industry-first AI-driven video analysis tool designed to simplify complex medical data by emphasizing key health parameters and explaining their relevance, effectively guiding users through their health reports. This groundbreaking feature allows users to receive personalized insights within 15-30 minutes after completing a brief questionnaire on the Healthians app, thereby enhancing their capacity to make informed health decisions.

Major players in the precision diagnostics market are embracing a strategic partnership approach to provide personalized and precision-focused healthcare. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For instance, in September 2023, Owkin, a France-based AI biotech company, partnered with Tribun Health, a provider of computational pathology solutions based in France, to improve the development and global deployment of AI-driven diagnostic and research solutions for pathology departments and pharmaceutical companies. By integrating Owkin's advanced AI diagnostics into Tribun Health's CaloPix platform, this collaboration aims to streamline pathology data workflows and enhance diagnostic accuracy, ultimately accelerating personalized treatment options for patients.

In February 2022, SQI Diagnostics Inc., a Canada-based precision medicine company, acquired Precision Biomonitoring Inc. for $6,825,000. This acquisition aims to expand SQI's human diagnostic business portfolio by incorporating Precision Biomonitoring's TripleLock molecular diagnostic testing technology. Precision Biomonitoring Inc., a Canada-based biotechnology and research company, specializes in providing precision diagnostic services, including DNA-based surveillance and detection.

Major companies operating in the precision diagnostics market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Abbott Laboratories, Danaher Corporation, Amgen Inc., Koninklijke Philips N.V., Becton Dickinson and Company (BD), Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Siemens Healthineers AG, Agilent Technologies Inc., PerkinElmer Inc., Beckman Coulter Inc., Charles River Laboratories International Inc., Sysmex America Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Bio-Techne Corporation, Illumina Inc., Lantheus Medical Imaging Inc., Luminex Corporation, BioFire Diagnostics LLC, Genomic Health Inc., Swiss Precision Diagnostics GmbH, Bluebird Bio Inc.

North America was the largest region in the precision diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the precision diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision diagnostics market consists of revenues earned by entities by providing precision imaging, molecular imaging, on-device X-ray AI algorithms, and automated MR workflow. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision diagnostics market also includes sales of medical diagnostic kits, rapid test kits, instruments and analyzers, and diagnostic equipment which are used in precision diagnostics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for precision diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Precision Diagnostics Market Characteristics

3. Precision Diagnostics Market Trends And Strategies

4. Precision Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Precision Diagnostics Growth Analysis And Strategic Analysis Framework

6. Precision Diagnostics Market Segmentation

7. Precision Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Precision Diagnostics Market

9. China Precision Diagnostics Market

10. India Precision Diagnostics Market

11. Japan Precision Diagnostics Market

12. Australia Precision Diagnostics Market

13. Indonesia Precision Diagnostics Market

14. South Korea Precision Diagnostics Market

15. Western Europe Precision Diagnostics Market

16. UK Precision Diagnostics Market

17. Germany Precision Diagnostics Market

18. France Precision Diagnostics Market

19. Italy Precision Diagnostics Market

20. Spain Precision Diagnostics Market

21. Eastern Europe Precision Diagnostics Market

22. Russia Precision Diagnostics Market

23. North America Precision Diagnostics Market

24. USA Precision Diagnostics Market

25. Canada Precision Diagnostics Market

26. South America Precision Diagnostics Market

27. Brazil Precision Diagnostics Market

28. Middle East Precision Diagnostics Market

29. Africa Precision Diagnostics Market

30. Precision Diagnostics Market Competitive Landscape And Company Profiles

31. Precision Diagnostics Market Other Major And Innovative Companies

32. Global Precision Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Precision Diagnostics Market

34. Recent Developments In The Precision Diagnostics Market

35. Precision Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기